Search
Search Results
##search.searchResults.foundPlural##
-
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1675PDF: 811HTML: 223 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2640PDF: 892HTML: 17578Fig1 Caligaris: 193Fig.2 Caliga: 236 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1798PDF: 892HTML: 413Fig1: 249Fig.2: 261Fig. 3: 199Fig. 5: 211Fig. 4: 234 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1325PDF: 516HTML: 238 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3376PDF: 595HTML: 692 -
-
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2521PDF: 803HTML: 1743 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1690PDF: 661HTML: 2440 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1420PDF: 873HTML: 179 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4356PDF: 1506HTML: 8524 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2580PDF: 960HTML: 425 -
MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS
3356PDF: 735HTML: 738Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 196Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 196Table : Distribution of the sites of bleeding and their causes: 191 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1872PDF: 1188HTML: 289 -







